Herpes simplex virus keratitis: Histopathology and corneal allograft outcomes

Expert Review of Ophthalmology

Volumn 5, Issue 2, 2010, Pages 129-134

  Shtein, Roni M ^a   Elner, Victor M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Allograft failure; Allograft rejection; Herpes simplex virus; Histopathology; Inflammation; Keratitis; Neovascularization; Penetrating keratoplasty

Indexed keywords

ANTIVIRUS AGENT; BEVACIZUMAB; CORTICOSTEROID; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

BIOMICROSCOPY; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; DISEASE SEVERITY; GRAFT FAILURE; GRAFT REJECTION; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; INNATE IMMUNITY; KERATITIS; MOLECULAR BIOLOGY; PATHOGENESIS; PATIENT MONITORING; PENETRATING KERATOPLASTY; PREDICTION; REVIEW; TREATMENT OUTCOME;

EID: 77951628080     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/eop.10.12     Document Type: Review

References (33)

1. Wickham S, Carr DJJ. Molecular mimicry versus bystander activation herpetic stromal keratitis. Autoimmunity 37, 393-397 (2004).
2. Araki-Sasaki K, Tanaka T, Ebisuno Y et al. Dynamic expression of chemokines and the infltration of infammatory cells in the HSV-infected cornea and its associated tissues. Ocul. Immunol. Infamm. 14(5), 257-266 (2006).
3. Inoue Y. Immunologic aspects of herpetic stromal keratitis. Semin. Opthamol. 23(4), 221-227 (2008).
4. Komatsu K, Miyazaki D, Morohoshi K et al. Pathogenesis of herpetic stromal keratitis in CCR5-and/or CXCR3-defcient mice. Curr. Eye Res. 33(9), 736-749 (2008).
5. Li H, Zhang J, Kumar A, Zheng M, Atherton SS, Yu FS. Herpes simplex virus 1 infection induces the expression of proinfammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology 117(2), 167-176 (2006).
6. Hayashi K, Hooper LC, Chin MS, Nagineni CN, Detrick B, Hooks JJ. Herpes simplex virus 1 (HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. J. Gen. Virol. 87(8), 2161-2169 (2006).
7. Divito SJ, Hendricks RL. Activated infammatory infltrate in HSV-1-infected corneas without herpes stromal keratitis. Invest. Ophthalmol. Vis. Sci. 49, 1488-1495 (2008).
8. Biswas PS, Banarjee K, Kim B, Kinchington PR, Rouse BT. Role of infammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis. J. Virol. 79(16), 10589-10600 (2005).
9. Lee S, Zheng M, Kim B, Rouse BT. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J. Clin. Invest. 110(8), 1105-1111 (2002).
10. Biswas PS, Banarjee K, Kinchington PR, Rouse BT Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp. Eye Res. 82, 46-54 (2006).
11. Biswas PS, Banerjee K, Zheng M, Rouse BT Counteracting corneal immunoinfammatory lesion with interleukin-1 receptor antagonist protein. J. Leukoc. Biol. 76(4), 868-875 (2004).
12. Kim B, Tang Q, Biswas PS et al. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am. J. Pathol. 165(6), 2177-2185 (2004).
13. Saravia M, Zapata G, Ferraiolo P, Racca L, Berra A. Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and infammation in a rabbit model of herpetic stromal keratitis. Graefes. Arch. Clin. Exp. Ophthalmol 247(10), 1409-1416 (2009).
14. Gerten G. Bevacizumab (avastin) and argon laser to treat neovascularization in corneal transplant surgery. Cornea 27(10), 1195-1199 (2008).
15. Kim SW, Ha BJ, Kim EK, Tchah H, Kim TI. The effect of topical bevacizumab on corneal neovascularization. Ophthalmology 115(6), e33-e38 (2008).
16. Doctor PP, Bhat PV, Foster CS. Subconjunctival bevacizumab for cornealneo vascularization. Cornea 27(9), 992-995 (2008).
17. Garcia DD, Farjo Q, Musch DC, Sugar A. Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 26, 930-934 (2007).
18. Ghosh S, Jhanji V, Lamoureux E, Taylor HR, Vajpayee RB. Acyclovir therapy in prevention of recurrent herpetic keratitis following penetrating keratoplasty. Am. J. Ophthalmol. 145, 198-202 (2008).
19. Shtein RM, Garcia DD, Musch DC, Elner VM. Herpes simplex virus keratitis: histopathologic infammation and corneal allograft rejection. Ophthalmology 116, 1301-1305 (2009).
20. Shtein RM, Garcia DD, Musch DC, Elner VM. HSV Keratitis: histopathologic predictors of corneal allograft outcomes. Trans. Am. Ophthalmol. Soc. 106, 161-170 (2008).
21. Garcia DD, Shtein RM, Musch DC, Elner VM. Herpes simplex virus keratitis: histopathologic neovascularization and corneal allograft failure. Cornea 28, 963-965 (2009).
22. Branco BC, Gaudio PA, Margolis TP. Epidemiology and molecular analysis of herpes simplex keratitis requiring primary penetrating keratoplasty. Br. J. Ophthalmol 88(10), 1285-1288 (2004).
23. Léger F, Vital C, Négrier ML, Bloch B. Histologic fndings in a series of 1,540 corneal allografts. Ann. Pathol. 21(1), 6-14 (2001).
24. Robert PY, Adenis JP, Denis F, Alain S, Ranger-Rogez S. Herpes simplex virus DNA in corneal transplants: prospective study of 38 recipients. J. Med. Virol. 71(1), 69-74 (2003).
25. Aydemir O, Türkçüoglu P, Bulut Y, Kalkan A. The relationship of graft survival and herpes simplex virus latency in recipient corneal buttons. Clin. Ophthalmol. 1(2), 127-131 (2007).
26. Remeijer L, Duan R, van Dun JM, Wefers Bettink MA, Osterhaus AD, Verjans GM. Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues. J. Infect. Dis. 200(1), 11-19 (2009).
27. Shimomura Y, Deai T, Fukuda M, Higaki S, Hooper LC, Hayashi K. Corneal buttons obtained from patients with HSK harbor high copy numbers of the HSV genome. Cornea 26(2), 190-193 (2007).
28. Zheng X. Reactivation and donor-host transmission of herpes simplex virus after corneal transplantation. Cornea 21(7 Suppl.), S90-S93 (2002).
29. Remeijer L, Maertzdorf J, Doornenbal P et al. Herpes simplex virus 1 transmission through corneal transplantation. Lancet 357, 442 (2001).
30. Borderie VM, Meritet J-F, Chaumeil C et al. Culture-proven herpetic keratitis after penetrating keratoplasty in patients with no previous history of Herpes disease. Cornea 23, 118-124 (2004).
31. Sarnicola V, Toro P. Deep anterior lamellar keratoplasty in herpes simplex corneal opacities. Cornea 29, 60-64 (2010).
32. Leccisotti A. Air-assisted manual deep anterior lamellar keratoplasty for treatment of herpetic corneal scars. Cornea 28, 728-731 (2009).
33. Hillenaar T, Weenen C, Wubbels RJ, Remeijer L. Endothelial involvement in herpes simplex virus keratitis: an in vivo confocal microscopy study. Ophthalmology 116, 2077-2086 (2009).